ARL8B regulates lysosomal function and predicts poor prognosis in hepatocellular carcinoma
Liyan Wu,
No information about this author
Zelin Weng,
No information about this author
Xia Yang
No information about this author
et al.
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: April 10, 2025
Language: Английский
Development and validation of a novel lysosome-related LncRNA signature for predicting prognosis and the immune landscape features in colon cancer
Fengming Li,
No information about this author
Wenyi Wang,
No information about this author
Guanbiao Lai
No information about this author
et al.
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: Jan. 5, 2024
Abstract
Lysosomes
are
essential
components
for
managing
tumor
microenvironment
and
regulating
growth.
Moreover,
recent
studies
have
also
demonstrated
that
long
non-coding
RNAs
could
be
used
as
a
clinical
biomarker
diagnosis
treatment
of
colorectal
cancer.
However,
the
influence
lysosome-related
lncRNA
(LRLs)
on
progression
colon
cancer
is
still
unclear.
This
study
aimed
to
identify
prognostic
LRL
signature
in
elucidated
potential
biological
function.
Herein,
10
differential
expressed
genes
were
obtained
by
TCGA
database
ultimately
4
LRLs
conducting
risk
model
identified
co-expression,
univariate
cox,
least
absolute
shrinkage
selection
operator
analyses.
Kaplan–Meier
analysis,
principal-component
functional
enrichment
annotation,
nomogram
verify
model.
Besides,
association
between
immune
infiltration,
chemotherapeutic
drugs
sensitivity
discussed
this
study.
based
may
promising
prognosis
immunotherapeutic
responses
related
indicator
patients.
Language: Английский
Establishment of a lysosome-related prognostic signature in breast cancer to predict immune infiltration and therapy response
Frontiers in Oncology,
Journal Year:
2023,
Volume and Issue:
13
Published: Dec. 14, 2023
Background
Lysosomes
are
instrumental
in
intracellular
degradation
and
recycling,
with
their
functional
alterations
holding
significance
tumor
growth.
Nevertheless,
the
precise
role
of
lysosome-related
genes
(LRGs)
breast
cancer
(BC)
remains
elucidated.
This
study
aimed
to
establish
a
prognostic
model
for
BC
based
on
LRGs.
Methods
Employing
The
Cancer
Genome
Atlas
(TCGA)
cohort
as
training
dataset,
this
identified
differentially
expressed
(DLRGs)
through
intersecting
LRGs
differential
expression
(DEGs)
between
normal
samples.
A
was
subsequently
developed
using
Cox
regression
analysis
validated
within
two
Gene
Expression
Omnibus
(GEO)
external
validation
sets.
Further
analyses
explored
pathways,
immune
microenvironment,
immunotherapeutic
responses,
sensitivity
chemotherapeutic
drugs
different
risk
groups.
Additionally,
mRNA
protein
levels
were
examined
by
utilizing
Profiling
Interactive
Analysis
(GEPIA)
Human
Protein
(HPA)
databases.
Clinical
tissue
specimens
obtained
from
patients
gathered
validate
via
Real-Time
Polymerase
Chain
Reaction
(RT-PCR).
Results
We
five
specific
(ATP6AP1,
SLC7A5,
EPDR1,
SDC1,
PIGR).
overall
survival
(OS)
GEO
sets
(
p
=0.00034
GSE20685
=0.0095
GSE58812).
In
addition,
nomogram
incorporating
clinical
factors
showed
better
predictive
performance.
Compared
low-risk
group,
high-risk
group
had
higher
level
certain
cell
infiltration,
including
regulatory
T
cells
(Tregs)
type
2
helper
(Th2).
appeared
respond
less
well
general
immunotherapy
drugs,
according
Tumor
Immune
Dysfunction
Exclusion
(TIDE),
Immunophenotype
Score
(IPS),
drug
scores.
RT-PCR
results
trends
some
prognostic-related
agreement
previous
analysis.
Conclusion
Our
innovative
lysosome-associated
signature
can
predict
prognosis
patients,
offering
insights
guiding
subsequent
interventions.
Furthermore,
it
has
potential
provide
scientific
foundation
identifying
prospective
therapeutic
targets.
Language: Английский
Development of a prognostic model based on anoikis-related genes for predicting clinical prognosis and immunotherapy of hepatocellular carcinoma
Mu Pang,
No information about this author
Xizhe Sun,
No information about this author
Tingchao He
No information about this author
et al.
Aging,
Journal Year:
2023,
Volume and Issue:
15(19), P. 10253 - 10271
Published: Oct. 2, 2023
Hepatocellular
Carcinoma
(HCC)
is
the
predominant
cause
of
cancer-related
mortality
worldwide.
The
majority
HCC
patients
are
diagnosed
at
advanced
stages
disease,
with
a
high
likelihood
metastasis
and
unfavorable
prognosis.
Anoikis
resistance
crucial
factor
contributing
to
tumor
invasion
metastasis,
although
its
specific
role
in
remains
unclear.
Based
on
results
univariate
Cox
regression
least
absolute
shrink-age
selection
operator
(LASSO)
analysis,
subset
anoikis-related
genes
(ARGs)
significantly
associated
overall
survival
(OS)
was
identified.
A
multivariate
analysis
subsequently
identified
PDK4,
STK11,
TFDP1
as
three
prognostic
ARGs,
which
were
then
used
establish
risk
model.
Differences
OS
caused
by
stratification
demonstrated.
nomogram
indicated
that
ARGs
signature
served
an
independent
predictor.
In
vitro
experiments
further
confirmed
abnormal
expression
selected
HCC.
association
between
scores
examined
through
Kaplan-Meier
CIBERSORT
single-sample
gene
set
enrichment
(ssGSEA).
This
study
pioneering
effort
integrate
multiple
risk-predictive
model,
providing
unique
perspective
for
development
personalized
precise
therapeutic
strategies
Language: Английский
Identification of hypoxic-related lncRNAs prognostic model for revealing clinical prognostic and immune infiltration characteristic of cutaneous melanoma
Congjuan Liao,
No information about this author
Jiabao Yang,
No information about this author
Liuting Chen
No information about this author
et al.
Aging,
Journal Year:
2024,
Volume and Issue:
16(4), P. 3734 - 3749
Published: Feb. 15, 2024
Background:
Cutaneous
melanoma
(CM)
remains
a
significant
threat
to
human
health.
There
are
clues
the
potential
role
of
hypoxia
in
CM
progression.
However,
hypoxia-related
lncRNAs
(HRLs)
has
not
been
clarified.
Methods:
We
obtained
related
genes
from
MSigDB
database
and
subsequently
identified
HRLs
by
applying
TCGA
database.
LASSO-univariate
multivariate
Cox
analysis
were
used
comprehensively
analyze
survival
characteristics
expressions,
novel
HRLs-related
prognostic
risk
model
was
established
for
comprehensive
analysis.
Results:
The
could
evaluate
clinical
outcome
accurately.
ability
model-related
score
also
validated
as
an
independent
indicator
CM.
Immune
infiltration,
TMB
analysis,
drug
sensitivity
immunotherapy
evaluation
conducted
assess
possible
causes
difference
prognosis.
reliability
bioinformatics
results
partially
verified
RT-qPCR.
Conclusion:
new
discussed
development
CM,
which
provided
basis
stratification.
Language: Английский
Validation and identification of anoikis-related lncRNA signatures for improving prognosis in clear cell renal cell carcinoma
Zhenjie Zhu,
No information about this author
Qibo Wang,
No information about this author
Xiaowei Zeng
No information about this author
et al.
Aging,
Journal Year:
2024,
Volume and Issue:
16(4), P. 3915 - 3933
Published: Feb. 21, 2024
Clear
cell
carcinoma
(ccRCC)
usually
has
a
high
metastasis
rate
and
mortality
rate.
To
enable
precise
risk
stratification,
there
is
need
for
novel
biomarkers.
As
one
form
of
apoptosis,
anoikis
results
from
the
disruption
cell-cell
connection
or
cell-ECM
attachment.
However,
impact
anoikis-related
lncRNAs
on
ccRCC
not
yet
received
adequate
attention.
Language: Английский